Mar 26, 2026 08:33AM CDT Equity files two patents to expand tapinarof intellectual property

Mar 18, 2026 08:33AM CDT Equity stockholders approve all proposals at special meeting

Mar 5, 2026 08:30AM CDT Equity notes Sarborg patent filing for AI signature technology

Mar 4, 2026 08:30AM CDT acquires 20% stake in Sarborg for $115 million

Feb 20, 2026 08:31AM CDT Equity acquires 20% stake in Sarborg for $115 million

Jan 30, 2026 06:07AM Conduit Pharmaceuticals (CDT) files for 22.85M share offering by selling stockholders

Jan 2, 2026 08:32AM CDT engages NJS Foresight for solid-form licensing strategy

Oct 17, 2025 08:30AM CDT Equity purchases 9.26 bitcoin for $1 million

May 22, 2025 08:31AM Conduit Pharmaceuticals (CDT) Listing on Nasdaq Capital Market

May 21, 2025 08:32AM Conduit Pharmaceuticals (CDT) Regains Nasdaq Compliance

May 16, 2025 08:31AM Conduit Pharmaceuticals (CDT) Announces Reverse Stock Split

Mar 19, 2025 08:31AM Conduit Pharmaceuticals (CDT) Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Mar 6, 2025 09:38AM Conduit Pharmaceuticals (CDT) Provides Update on Nasdaq Stock Market Hearing Panel

Jan 23, 2025 08:00AM Conduit Pharmaceuticals (CDT) Announces 1:100 Reverse Share Split

Nov 25, 2024 05:18PM Conduit Pharmaceuticals (CDT) Files for 75M Share Offering by Selling Stockholders

Oct 24, 2024 06:17AM Conduit Pharmaceuticals (CDT) Files $100M Mixed Shelf

Sep 4, 2024 04:55PM Conduit Pharmaceuticals (CDT) Files for 22M Share Offering by Selling Stockholders

Jul 16, 2024 07:31AM Conduit Pharmaceuticals (CDT) Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases